The bulk drug manufacturer's ANDA for dimethyl fumarate delayed-release capsules was granted approval by the US drug regulator. The stock of Shilpa Medicare was buzzing on Thursday and gained 5 per cent in the morning session.

Having your own house is a dream of every individual and leveraging savings for buying a home is very normal practice in India. But can renting a house instead of buying eventually make you crorepati? Read on to find out more.

Overall volumes in futures & options currently stand at 2.89 crore contracts with a turnover of Rs. 15,60,701.67 crore.

Overall volumes in futures & options currently stand at 2.89 crore contracts with a turnover of Rs. 15,60,701.67 crore.

Unless Nifty successfully moves past the hurdle of 10,650, we do not see any significant move in the index. On the downside, immediate support is seen around the level of 10,530, followed by 10,440.  Stocks in news: Venus Remedies, Tata Sponge Iron, SRF, Yes Bank, Lemon Tree, Infosys and Bank of Baroda.

The diminishing prospects of an all-out trade war and the rupee rallies to two-month high to close below 72-mark against the US dollar are a big boost for the Indian markets and thus we could see an optimistic start to the day. The SGX Nifty Index Future has nearly gained 0.38 per cent, suggesting Nifty may open around the level of 10,663.  

In the short-term, Rs 575-570 is likely to act as a strong support zone. While the momentum is likely to been seen when the stock manages to sustain above the recent swing of Rs. 637 per share.

Risk is as important as return while choosing an investment vehicle. Read on to find the most common type of risk and how to use them.

Non-banking finance company Sundaram Finance which holds a majority stake in Royal Sundaram has signed an agreement with Ageas International to divest 40 per cent stake for a total consideration of Rs. 1,520 crore.

Following stocks are close to their 52-week low as at 1.06 p.m. on November 15, 2018.